Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization

The final analysis comes just one week after initial results from the trial showed the vaccine was more than 90% effective. Moderna Inc on Monday released preliminary data for its vaccine, showing similar effectiveness.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3lGZgP7
via IFTTT